文献速递头颈外科

头颈癌患者的肺癌监测

Lung Cancer Surveillance for Patients With Head and Neck Cancer.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2025-01-01

这项在加拿大某大型学术医院开展的随机平行试验纳入137例初治头颈部鳞状细胞癌患者,随机分入胸片组(68例)或低剂量CT组(69例)进行肺部转移和/或第二原发肺癌筛查。低剂量CT灵敏度(100%)与特异度(100%)均高于胸片(灵敏度66.7%、特异度100%),但两组生存结局无临床意义差异(HR 1.2,95%CI 0.4-3.9)。

要点

  • 低剂量CT筛查肺癌灵敏度100%、特异度100%,胸片灵敏度66.7%、特异度100%。
  • 两组生存结局无临床意义差异,HR 1.2(95%CI 0.4-3.9)。
  • 137例中9例(6.5%)发生第二原发肺癌(6例)或肺转移(3例)。

核心结论

  • 低剂量CT在诊断肺转移和第二原发肺癌方面灵敏度显著优于胸片,但两组生存率无重要差异。

研究设计与样本

  • 随机平行试验,在加拿大某大型学术医院开展,2015年9月至2022年12月纳入初治新发头颈部鳞状细胞癌患者,随机分为胸片组68例(49.6%)和低剂量CT组69例(50.4%),共137例。
  • 入组患者不符合美国国家综合癌症网络指南制定的肺癌筛查标准。
  • 数据分析时间为2024年3月至8月。

主要发现

  • 137例患者平均年龄65.1岁(SD 14.1),女性34例(24.8%)、男性103例(75.2%)。
  • 137例中9例(6.5%)发生第二原发肺癌(6例)或肺转移(3例)。
  • 两组生存结局无临床意义差异,风险比1.2(95%CI 0.4-3.9)。
  • 胸片灵敏度66.7%、特异度100%;低剂量CT灵敏度100%、特异度100%,总体准确率100%。

关键数值与推荐

  • 胸片灵敏度66.7%、特异度100%;低剂量CT灵敏度100%、特异度100%,总体准确率100%。
  • 两组生存结局风险比1.2(95%CI 0.4-3.9)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patients with head and neck squamous cell cancer (HNSCC) are at a greater risk of developing pulmonary metastases and/or second primary lung cancer. However, it remains uncertain whether lung screening in these patients, when the initial staging studies are negative, confers any survival benefit. OBJECTIVE: To evaluate long-term cancer survival outcomes in patients with HNSCC undergoing chest radiography vs low-dose computed tomography screening for pulmonary metastasis and/or second primary lung cancer. DESIGN, SETTING, AND PARTICIPANTS: This randomized parallel trial was conducted at a large academic hospital in Canada enrolling treatment-naive patients with de novo HNSCC from September 2015 to December 2022. Eligible patients did not meet the criteria for lung screening established by the US National Comprehensive Cancer Network guidelines. Participants were randomized to chest radiography or low-dose computed tomography screening groups. Data were analyzed from March to August 2024. INTERVENTION OR EXPOSURE: Comparison of chest radiography vs low-dose computed tomography screening methods. MAIN OUTCOMES AND MEASURES: Primary outcomes were the lung cancer detection rate measured by comparing the sensitivity and specificity of low-dose computed tomography with chest radiography. Secondary outcomes were overall survival and disease-free survival. RESULTS: A total of 137 patients (mean [SD] age, 65.1 [14.1] years; 34 [24.8%] females and 103 [75.2%] males) were included and randomized, 68 (49.6%) to chest radiography and 69 (50.4%) to low-dose computed tomography. Nine of 137 patients (6.5%) developed a second primary lung cancer (6 patients) or lung metastases (3 patients). There were no clinically meaningful differences in survival outcomes between the 2 groups (hazard ratio, 1.2; 95% CI, 0.4-3.9). Chest radiography exhibited a relatively low sensitivity of 66.7% but a specificity of 100%. Low-dose computed tomography demonstrated both high sensitivity (100%) and specificity (100%), for an overall accuracy of 100%. CONCLUSIONS AND RELEVANCE: The findings of this randomized parallel trial indicate that low-dose computed tomography exhibits statistically significant superior sensitivity compared with chest radiography for diagnosing lung metastases and second primary lung cancer. However, there were no important differences in survival rates. These results hold practical significance, offering valuable insights to clinicians who are guiding decisions regarding lung screening protocols. TRIAL REGISTRATION: ISRCTN10954990.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Fnais N, Laxague F, Mascarella MA, et al. Lung Cancer Surveillance for Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 40048159. doi:10.1001/jamaoto.2024.3738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。